Company Filing History:
1 out of 261 
1 out of 1,736 
Years Active: 2017-2023
Title: Zehra Ilhan: Innovator in Microbiome Research
Introduction
Zehra Ilhan is a prominent inventor based in Tempe, Arizona, known for her groundbreaking work in microbiome research. She has been instrumental in advancing our understanding of the gut microbiome and its implications for health, particularly in relation to autism spectrum disorders. With two patents to her name, her contributions are paving the way for potential diagnostic and therapeutic targets.
Latest Patents
Zehra Ilhan's latest patents focus on microbiome markers and therapies for autism spectrum disorders. The disclosures provide a comprehensive characterization of normal flora and the identification of biomarkers in the gut of healthy, neurotypical subjects. The research highlights the differences in gut microbiome composition between autistic and neurotypical children, noting a significant reduction in the richness and diversity of gut microbiota in the autistic group. Specifically, the relative abundance of genera such as Prevotellaceae and Veillonellaceae is significantly lower in autistic children compared to their neurotypical counterparts. This work offers valuable insights into the association between gut microbiota, health, and disease states.
Career Highlights
Throughout her career, Zehra Ilhan has worked with notable institutions, including the Arizona Board of Regents and Arizona State University. Her research has garnered attention for its innovative approach to understanding the gut microbiome's role in health and disease.
Collaborations
Zehra has collaborated with esteemed colleagues such as Rosa Krajmalnik-Brown and Dae-Wook Kang, contributing to a rich exchange of ideas and research in the field of microbiome studies.
Conclusion
Zehra Ilhan's work in microbiome research is making significant strides in understanding the complexities of gut health and its impact on autism spectrum disorders. Her innovative patents and collaborations are setting the stage for future advancements in this critical area of study.